Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Free Cash Flow (2016 - 2017)

Tenax Therapeutics' Free Cash Flow history spans 8 years, with the latest figure at -$1.3 million for Q4 2017.

  • For Q4 2017, Free Cash Flow rose 58.71% year-over-year to -$1.3 million; the TTM value through Dec 2017 reached -$12.1 million, up 23.49%, while the annual FY2025 figure was -$35.8 million, 141.71% down from the prior year.
  • Free Cash Flow for Q4 2017 was -$1.3 million at Tenax Therapeutics, down from -$1.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.2 million in Q3 2017 and bottomed at -$60.8 million in Q4 2013.
  • The 5-year median for Free Cash Flow is -$3.2 million (2015), against an average of -$9.1 million.
  • The largest annual shift saw Free Cash Flow crashed 1284.34% in 2013 before it skyrocketed 96.79% in 2014.
  • A 5-year view of Free Cash Flow shows it stood at -$60.8 million in 2013, then soared by 95.21% to -$2.9 million in 2014, then tumbled by 32.52% to -$3.9 million in 2015, then rose by 19.55% to -$3.1 million in 2016, then skyrocketed by 58.71% to -$1.3 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Free Cash Flow are -$1.3 million (Q4 2017), -$1.2 million (Q3 2017), and -$5.6 million (Q2 2017).